Evidence map›Paper›PMID 21908846›Full record

ArticleThe Journal of biological chemistry2011

Analysis of mutations that dissociate G(2) and essential S phase functions of human ataxia telangiectasia-mutated and Rad3-related (ATR) protein kinase.

Edward A Nam, Runxiang Zhao, David Cortez

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.8field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. DNA damage response: three levels of DNA repair regulation.Cold Spring Harbor perspectives in biology · 2013
    Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Edward A NamDepartment of Cancer Biology, Vanderbilt University School of Medicine, Nashville, Tennessee 37232, USA.
Runxiang Zhao
David Cortez
Vanderbilt University · US

Funding

Structural Biology Facility CoreP30ES000267 · NIEHS · VANDERBILT UNIVERSITY · PI GUENGERICH, F PETER · 1985 to 2014
$20.3M
Function of the ATR-ATRIP ComplexR01CA102729 · NCI · VANDERBILT UNIVERSITY · PI CORTEZ, DAVID K · 2003 to 2018
$4.2M
NCI NIH HHS CA06485NCI NIH HHS R01 CA102729NCI NIH HHS R01CA102729NIEHS NIH HHS P30 ES000267NIEHS NIH HHS P30ES000267
6 · The paper itself

Abstract

ATR (ataxia telangiectasia-mutated and Rad3-related) contains 16 conserved candidate autophosphorylation sites that match its preferred S/TQ consensus. To determine whether any is functionally important, we mutated the 16 candidate residues to alanine in a single cDNA to create a 16A-ATR mutant. The 16A-ATR mutant maintains kinase and G(2) checkpoint activities. However, it fails to rescue the essential function of ATR in maintaining cell viability and fails to promote replication recovery from a transient exposure to replication stress. Further analysis identified T1566A/T1578A/T1589A (3A-ATR) as critical mutations causing this separation of function activity. Secondary structure predictions indicate that these residues occur in a region between ATR HEAT repeats 31R and 32R that aligns with regions of ATM and DNA-PK containing regulatory autophosphorylation sites. Although this region is important for ATR function, the 3A-ATR residues do not appear to be sites of autophosphorylation. Nevertheless, our analysis identifies an important regulatory region of ATR that is shared among the PI3K-related protein kinase family. Furthermore, our data indicate that the essential function of ATR for cell viability is linked to its function in promoting proper replication in the context of replication stress and is independent of G(2) checkpoint activity.

Indexed as

Mutation, MissenseAmino Acid SubstitutionAtaxia Telangiectasia Mutated ProteinsCell Cycle ProteinsCell LineCell SurvivalDNA-Activated Protein KinaseDNA-Binding ProteinsG2 PhaseHumansPhosphorylationProtein Serine-Threonine KinasesProtein Structure, SecondaryS PhaseTumor Suppressor ProteinsAtaxia Telangiectasia Mutated ProteinsATM protein, humanATR protein, humanCell Cycle ProteinsDNA-Activated Protein KinaseDNA-Binding ProteinsProtein Serine-Threonine KinasesTumor Suppressor Proteins

Identifiers

PMID21908846
PMCPMC3199479
OpenAlexW2056912104

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.